logo

For the Inventor, By the Inventor

Yardley, PA, United States of America

Wei Han

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb Pharma Company. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wei Han. Retrieved from https://idiyas.com/inventor/wei-han-1sc0ew4c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 87.5



Average Co-Inventor Count = 2.9

ph-index = 9

Forward Citations = 324(Granted Patents)


Location History:

  • Newark, DE (US) (2003 - 2006)
  • Yardley, PA (US) (2005 - 2013)

Company Filing History:

goldMedal12 out of 3,737 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal4 out of 234 
 
Bristol-Myers Squibb Pharma Company
 patents

Years Active: 2003-2013

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 8466295 - Thiophene derivatives as factor XIa inhibitors (2013-06-18),
2. 7524863 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2009-04-28),
3. 7507730 - Substituted pyrazolo[1,5-a]pyrimidines as potassium channel activators (2009-03-24),
4. 7371761 - Lactam-containing compounds and derivatives thereof as factor Xa inhibitors (2008-05-13),
5. 7312218 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2007-12-25),
6. 7312214 - 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors (2007-12-25),
7. 7199149 - Monocyclic and bicyclic lactams as factor Xa inhibitors (2007-04-03),
8. 7169795 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2007-01-30),
9. 7157470 - Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors (2007-01-02),
10. 7115627 - Glycinamides as factor Xa inhibitors (2006-10-03),
11. 6995172 - Lactam-containing compounds and derivatives thereof as factor Xa inhibitors (2006-02-07),
12. 6967208 - Lactam-containing compounds and derivatives thereof as factor Xa inhibitors (2005-11-22),
13. 6844318 - Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use (2005-01-18),
14. 6774212 - Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease (2004-08-10),
15. 6699855 - Inhibitors of hepatitis C virus NS3 protease (2004-03-02),

Title: Inventor Wei Han: Pioneering Innovations in Yardley

Introduction: Wei Han is a distinguished inventor based in Yardley, Pennsylvania, known for his groundbreaking contributions to various technological fields.

Latest Patents: Wei Han holds several patents in the areas of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to driving progress through innovation.

Career Highlights: With a career spanning over two decades, Wei Han has worked with leading research institutions and tech companies, playing a pivotal role in developing cutting-edge solutions that have reshaped industries.

Collaborations: Wei Han has collaborated with top engineers, scientists, and designers globally, fostering a culture of creativity and excellence that has led to the successful implementation of numerous pioneering projects.

Conclusion: Wei Han's passion for innovation, coupled with his relentless pursuit of excellence, continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…